Name
ImmunoGen, Inc.
Company Description
ImmunoGen is developing the next generation of antibody-drug conjugates to improve outcomes for cancer patients. By generating targeted therapies with enhanced anti-tumor activity and favorable tolerability profiles, we aim to disrupt the progression of cancer and offer our patients more good days. We call this our commitment to TARGET A BETTER NOW™. ImmunoGen is now part of AbbVie. Learn more about who we are, what we do, and how we do it at abbvie.com/oncology or elahere.com.
Website
Featured Exhibitor
Yes
Product Categories (7)
Gynecologic Cancer, Hematologic Cancers, Biomarkers, Clinical Trials, Pharmaceutical
Conquer Cancer Council Member
Yes
Phone (If provided, phone will display online and in-print)
781-895-0600
Address
Waltham, MA
United States
United States
Recognition
Products
Relevance
